Change theme to redChange theme to blueChange theme to greenChoose your color

Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at


The invention is directed to stabilized whole-cell plasma, which retains the integrity and overall stability of the proteins and other macromolecules of the plasma. Stabilization is accomplished by the addition of glycine to plasma which allows for stabilization prior to freeze drying. Glycine, in the presence of the salt concentration in the plasma, does not recrystallize and acts as a superior stabilizer for the lyophilized plasma. The stability of the freeze dried plasma may be further improved by addition of protectants including calcium chloride, trisodium citrate, hydroxyethyl starch, ammonium sulfate and citric acid to maintain physiologic pH. Superior stability for a wide variety of plasma proteins and functions is shown. A system for the large scale preparation of sterile lyophilized plasma is also provided.

Docket:WRAIR 06-13

Publication/Issued No.:7,931,919

Publication/Issue Date:2011-04-26

Categories: Treatment

More Detail:Visit USPTO.GOVExternal link



For Licensing Opportunities, please contact the ORTA at

Last Modified Date: 28 Aug 2019

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRDC Public Affairs Office at: or by telephone at (301)619-2736